Nautilus Biotechnology Inc (NAUT)

$0.77 +0.03 (3.64%)
Market Cap 97.01M
Revenue (ttm) 0.00
Net Income (ttm) -70.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 234,600
Avg Vol 176,370
Day's Range N/A - N/A
Shares Out 126.15M
Stochastic %K 67%
Beta 1.43
Analysts Sell
Price Target $2.06

Latest News on NAUT

Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 1:01 PM EDT - 5 weeks ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript

Nautilus: Trading Below An Albeit Lower Net Cash Figure

Feb 28, 2025, 6:59 PM EST - 3 months ago

Nautilus: Trading Below An Albeit Lower Net Cash Figure

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 7:25 AM EST - 3 months ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript

Nautilus Biotechnology layoffs 16% of workforce, plans release of commercial platform in 2026

Feb 27, 2025, 9:50 AM EST - 3 months ago

Nautilus Biotechnology layoffs 16% of workforce, plans release of commercial platform in 2026

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Oct 31, 2024, 8:00 AM EDT - 7 months ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

Oct 30, 2024, 8:00 AM EDT - 7 months ago

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 1:17 PM EDT - 7 months ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 3:16 PM EDT - 11 months ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 8:00 AM EDT - 11 months ago

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

Jul 9, 2024, 8:00 AM EDT - 11 months ago

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 1:19 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 1:13 PM EST - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 28, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Feb 22, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 8:00 AM EST - 1 year ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Nov 30, 2023, 8:00 AM EST - 1 year ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Nov 1, 2023, 8:05 AM EDT - 1 year ago

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 11:22 AM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Oct 31, 2023, 8:05 AM EDT - 1 year ago

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Oct 11, 2023, 8:05 AM EDT - 1 year ago

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Aug 4, 2023, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 1:33 PM EDT - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 7:30 AM EDT - 2 years ago

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

Jul 11, 2023, 9:23 AM EDT - 2 years ago

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

May 24, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

May 2, 2023, 6:30 AM EDT - 2 years ago

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

Apr 18, 2023, 4:05 PM EDT - 2 years ago

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Mar 23, 2023, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript

Feb 25, 2023, 3:09 PM EST - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Feb 23, 2023, 6:05 AM EST - 2 years ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

Feb 21, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Jan 26, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Nautilus Biotechnology Expands to San Diego

Jan 26, 2023, 7:45 AM EST - 2 years ago

Nautilus Biotechnology Expands to San Diego

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

Jan 19, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

Dec 27, 2022, 10:53 AM EST - 2 years ago

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript

Nov 1, 2022, 2:35 PM EDT - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

Nov 1, 2022, 6:05 AM EDT - 2 years ago

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Sep 23, 2022, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Sep 1, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

Aug 30, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript

Aug 2, 2022, 12:02 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

Aug 2, 2022, 6:48 AM EDT - 3 years ago

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

Jul 13, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q1 2022 Results - Earnings Call Transcript

May 3, 2022, 12:21 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q1 2022 Results - Earnings Call Transcript

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

May 3, 2022, 6:00 AM EDT - 3 years ago

Nautilus Biotechnology Reports First Quarter 2022 Financial Results

Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

Apr 7, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

Nautilus Biotechnology to Present at EuPA and AACR Meetings

Apr 4, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Present at EuPA and AACR Meetings

Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors

Mar 31, 2022, 4:05 PM EDT - 3 years ago

Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors